Nu Skin Enterprises, Inc. (NUS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NUS Revenue Growth
Revenue Breakdown (FY 2025)
NUS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
NUS Revenue Analysis (2014–2025)
As of May 8, 2026, Nu Skin Enterprises, Inc. (NUS) generated trailing twelve-month (TTM) revenue of $1.49 billion, reflecting significant decline in growth of -16.9% year-over-year. The most recent quarter (Q4 2025) recorded $370.3 million in revenue, up 1.7% sequentially.
Looking at the longer-term picture, NUS's 5-year compound annual growth rate (CAGR) stands at -10.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $2.70 billion in 2021.
Revenue diversification analysis shows NUS's business is primarily driven by Manufacturing Segment (92%), Rhyz Other Segment (8%), and Nu Skin (1%). With over half of revenue concentrated in Manufacturing Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Consumer Defensive sector peers including HLF (+3.7% YoY), USNA (+8.3% YoY), and NATR (+7.3% YoY), NUS has underperformed the peer group in terms of revenue growth. Compare NUS vs HLF →
NUS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NUSCurrent | $1.5B | -16.9% | -10.5% | 6.1% | |
 HLF | $5.0B | +3.7% | -1.9% | 8.8% | |
 USNA | $925M | +8.3% | -4.0% | 5.5% | |
 NATR | $480M | +7.3% | +4.5% | 5.2% | |
 MED | $386M | -36.3% | -16.2% | -3.7% | |
 EL | $14.3B | +0.4% | -0.0% | 6.7% |
NUS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.49B | -14.3% | $1.03B | 69.4% | $90.9M | 6.1% |
| 2024 | $1.73B | -12.0% | $1.18B | 68.2% | $-151,585,000 | -8.8% |
| 2023 | $1.97B | -11.5% | $1.36B | 68.9% | $48.3M | 2.5% |
| 2022 | $2.23B | -17.4% | $1.59B | 71.7% | $110.8M | 5.0% |
| 2021 | $2.70B | +4.4% | $2.02B | 75.0% | $234.0M | 8.7% |
| 2020 | $2.58B | +6.7% | $1.92B | 74.5% | $257.6M | 10.0% |
| 2019 | $2.42B | -9.7% | $1.84B | 76.0% | $267.4M | 11.0% |
| 2018 | $2.68B | +17.5% | $2.04B | 76.3% | $240.9M | 9.0% |
| 2017 | $2.28B | +3.2% | $1.78B | 78.0% | $274.5M | 12.0% |
| 2016 | $2.21B | -1.7% | $1.71B | 77.3% | $231.1M | 10.5% |
See NUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NUS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NUS vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonNUS — Frequently Asked Questions
Quick answers to the most common questions about buying NUS stock.
Is NUS's revenue growth accelerating or slowing?
NUS revenue declined -16.9% year-over-year, contrasting with the 5-year CAGR of -10.5%. TTM revenue fell to $1.5B. This reverses the prior growth trend.
What is NUS's long-term revenue growth rate?
Nu Skin Enterprises, Inc.'s 5-year revenue CAGR of -10.5% reflects the variable expansion pattern. Current YoY growth of -16.9% is below this long-term average.
How is NUS's revenue distributed by segment?
NUS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.